Electra Therapeutics, Inc. (ETRA) Stock Forecast
ETRA analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 4 analysts
- Price target
- $33.33 average of analyst targets
- Upside to target
- +281.0% from the latest close
- Next earnings
- —
- 52-week range
- $8.61 – $15.00
ETRA analyst ratings
4 analystsNumber of analysts at each rating.
ETRA price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ETRA earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.44 | −$0.45 | −$0.42 | — | — | 3 |
| Current fiscal year (2026) | −$2.43 | −$2.92 | −$1.92 | −$1,408.52 | +99.8% | 3 |
| Next fiscal year (2027) | −$2.06 | −$2.30 | −$1.68 | −$2.43 | +15.3% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ETRA revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | — | 3 |
| Current fiscal year (2026) | $0 | $0 | $0 | — | 4 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 4 |
ETRA EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ETRA EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | $0.00 | −$0.44 | — | 0 up · 0 down |
| Current fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | −$2.43 | — | 0 up · 0 down |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | $0.00 | −$2.06 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
What analysts expect from ETRA
4 analysts cover Electra Therapeutics; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $33.33, 281.0% above the latest close of $8.75. Analysts expect earnings of −$2.43 per share for 2026, +99.8% from a year earlier. For 2027 the average estimate is −$2.06 per share.
Related: ETRA income statement, ETRA key metrics, ETRA chart. See the ETRA stock overview for the latest quote and news.
ETRA forecast FAQ
What is Electra Therapeutics's price target?
The average analyst price target for Electra Therapeutics is $33.33, 281.0% above the latest close of $8.75.
Is Electra Therapeutics a buy, hold or sell?
Of 4 analysts covering Electra Therapeutics, 4 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Electra Therapeutics's EPS forecast?
Analysts forecast −$2.43 per share for 2026 (range −$2.92 to −$1.92); for 2027 the estimate is −$2.06.